Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live

CAC 40 & Eli Lilly and Company

4 shared events · Importance 3 · Last updated Jun 30, 2026

Importance
3
Shared Events
4
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
24
Business
CAC 40: Slightly lower.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
20
International
CAC 40: The Paris CAC 40 index rose, contributing to the mixed but generally positive sentiment in Europepean markets.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 18, 2026 · 309 articles
20
International
CAC 40: The Paris CAC 40 index rose, contributing to the mixed but generally positive sentiment in Europepean markets.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 27, 2026 · 101 articles
0
International
Apr 01, 2026 · 23 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how CAC 40 and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.